XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
PHGE BiomX
- 0.9350
- +0.0462+5.20%
Close Feb 14 16:00 ET
- 0.9350
- 0.00000.00%
Post 20:01 ET
17.00MMarket Cap-0.29P/E (TTM)
0.9400High0.8610Low34.74KVolume0.9200Open0.8888Pre Close31.37KTurnover0.35%Turnover RatioLossP/E (Static)18.18MShares8.550052wk High0.88P/B9.31MFloat Cap0.480052wk Low--Dividend TTM9.96MShs Float119.0000Historical High--Div YieldTTM8.89%Amplitude0.4800Historical Low0.9020Avg Price1Lot Size
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025
BiomX Stock Forum
BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards
Monday, 16th December at 8:00 am
NESS ZIONA, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE: PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it received written notification from the NYSE American LLC ("NYSE American"), dated December 10, 2024, stati...
📊⚡️📊
Biomx Inc - FDA Grants Bx004 Fast Track and Orphan Drug Designation
BiomX Inc. (NYSE American: PHGE) has announced a 1-for-10 reverse stock splitof its common stock, effective August 26, 2024. The stock will continue trading under the symbol 'PHGE' with a new CUSIP number. This decision follows stockholder approval on July 9, 2024, and final ratio determination by the Board on August 8, 2024. The split will reduce outstanding shares from approximately 178,958,447 to 17,895,...
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
The findings will be presented in an oral presentation and an ePoster at the 47th European Cystic Fibrosis Conference, which is taking place June 5-8, 2024, in Glasgow, United Kingdom, and in a Rapid Fire oral presentation and a poster at the American Society for Microbiology (ASM) Microbe 2024 meeting, being held June 13-1...
No comment yet